Inhibitors of p38 MAP kinase increase the survival of transplanted dopamine neurons |
| |
Authors: | Zawada W M Meintzer M K Rao P Marotti J Wang X Esplen J E Clarkson E D Freed C R Heidenreich K A |
| |
Affiliation: | Department of Medicine, Division of Clinical Pharmacology, University of Colorado School of Medicine, Denver, CO 80262, USA. |
| |
Abstract: | Fetal cell transplantation therapies are being developed for the treatment of a number of neurodegenerative disorders including Parkinson's disease [10-12,21,22,24,36,43]. Massive apoptotic cell death is a major limiting factor for the success of neurotransplantation. We have explored a novel protein kinase pathway for its role in apoptosis of dopamine neurons. We have discovered that inhibitors of p38 MAP kinase (the pyridinyl imidazole compounds: PD169316, SB203580, and SB202190) improve survival of rat dopamine neurons in vitro and after transplantation into hemiparkinsonian rats. In embryonic rat ventral mesencephalic cultures, serum withdrawal led to 80% loss of dopamine neurons due to increased apoptosis. Incubation of the cultures with p38 MAP kinase inhibitors at the time of serum withdrawal prevented dopaminergic cell death by inhibiting apoptosis. In the hemiparkinsonian rat, preincubation of ventral mesencephalic tissue with PD169316 prior to transplantation accelerated behavioral recovery and doubled the survival of transplanted dopamine neurons. We conclude that inhibitors of stress-activated protein kinases improve the outcome of cell transplantation by preventing apoptosis of neurons after grafting. |
| |
Keywords: | Pyridinyl imidazole Apoptosis Parkinson’ s disease Neurodegeneration Neurotransplantation Dopamine neuron p38 MAP kinase |
本文献已被 ScienceDirect PubMed 等数据库收录! |
|